Related Experiment Video
Updated: Nov 7, 2025

Fabrication of Size-Controlled and Emulsion-Free Chitosan-Genipin Microgels for Tissue Engineering Applications
Published on: April 13, 2022
Recent Biomedical Approaches for Chitosan Based Materials as Drug Delivery Nanocarriers
Andreea Teodora Iacob1, Florentina Geanina Lupascu1, Maria Apotrosoaei1
1Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Grigore T. Popa University of Medicine and Pharmacy of Iasi, 16 University Street, 700115 Iasi, Romania.
Chitosan-based nanocarriers offer versatile, biocompatible drug delivery solutions. This review explores nanoparticles, nanofibers, and nanogels for targeted drug release across various medical applications.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Pharmaceutical Sciences
Background:
- Natural polymers are increasingly used in drug delivery systems (DDSs).
- Chitosan (CS) and its derivatives are highly investigated nanocarriers due to their favorable properties like biodegradability and biocompatibility.
- CS-based materials are fabricated into various forms including nanoparticles, nanofibers, and hydrogels for diverse applications.
Purpose of the Study:
- To review recent biomedical approaches utilizing chitosan-based nanocarriers.
- To highlight the potential applications of these nanocarriers in medical and pharmaceutical fields.
- To discuss the advantages and challenges of CS-based nanocarriers for different administration routes.
Main Methods:
- Literature review of recent biomedical approaches for chitosan-based nanocarriers.
- Focus on nanoparticles (NPs), nanofibers (NFs), nanogels (NGs), and chitosan-coated liposomes (LPs).
- Analysis of administration routes including oral, transmucosal, pulmonary, and transdermal.
Main Results:
- Chitosan-based nanocarriers demonstrate significant potential for controlled and targeted drug release.
- Various CS-based nanocarrier types (NPs, NFs, NGs, LPs) are suitable for delivering diverse therapeutic agents.
- Advantages and challenges for different administration routes are identified, comparing them to conventional formulations.
Conclusions:
- Chitosan-based nanocarriers represent a promising platform for advanced drug delivery.
- Further research into their application across various administration routes can optimize therapeutic outcomes.
- These nanocarriers hold significant potential for future pharmaceutical and medical innovations.
Related Concept Videos
Bioavailability Enhancement: Drug Permeability Enhancement
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Bioavailability Enhancement: Drug Solubility Enhancement
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Factors Affecting Dissolution: Particle Size and Effective Surface Area
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry

